Skip to Main Content

Author Details

Linzhao Cheng
Johns Hopkins University School of Medicine
1989
145
56
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36436185PEAR1 is a potential regulator of early hematopoiesis of human pluripotent stem cells.J Cell Physiol2023
34779029Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice.Am J Hematol2022
35399545In memory of Hal E. Broxmeyer, a pluripotent scientist, pioneer, and mentor.Blood Sci2022
33094331Transcriptional profile of platelets and iPSC-derived megakaryocytes from whole-genome and RNA sequencing.Blood2021
33829634Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells.J Thromb Haemost2021
33796838<i>HIF2A</i> gain-of-function mutation modulates the stiffness of smooth muscle cells and compromises vascular mechanics.iScience2021
33489014Highly efficient magnetic labelling allows MRI tracking of the homing of stem cell-derived extracellular vesicles following systemic delivery.J Extracell Vesicles2021
33484967BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.Mol Ther2021
31197070Sequential cellular niches control the generation of enucleated erythrocytes from human pluripotent stem cells.Haematologica2020
32011235Transcriptional landscape of myogenesis from human pluripotent stem cells reveals a key role of TWIST1 in maintenance of skeletal muscle progenitors.Elife2020
32916633Generation and characterization of a novel human iPSC line from a resilient Alzheimer's disease patient.Stem Cell Res2020
32845994Human Forebrain Organoids from Induced Pluripotent Stem Cells: A Novel Approach to Model Repair of Ionizing Radiation-Induced DNA Damage in Human Neurons.Radiat Res2020
32442913Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program.Stem Cell Res2020
32511247iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.PLoS One2020
30391800Human iPSC-derived blood-brain barrier microvessels: validation of barrier function and endothelial cell behavior.Biomaterials2019
31303172The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model.Fluids Barriers CNS2019
30811771Highly Purified Human Extracellular Vesicles Produced by Stem Cells Alleviate Aging Cellular Phenotypes of Senescent Human Cells.Stem Cells2019
29164808A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.Stem Cells Transl Med2018
29849122Heterozygous IDH1<sup>R132H/WT</sup> created by "single base editing" inhibits human astroglial cell growth by downregulating YAP.Oncogene2018
29554589Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system.Stem Cell Res2018
29101237Human <i>NOTCH4</i> is a key target of RUNX1 in megakaryocytic differentiation.Blood2018
27913985Erratum to: Questions about NgAgo.Protein Cell2017
28107356Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis.PLoS One2017
28395806Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.Stem Cell Res2017
28441409A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model.PLoS One2017
27037073A Method for Genome Editing in Human Pluripotent Stem Cells.Cold Spring Harb Protoc2016
26395760Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells.J Cell Physiol2016
27879207Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).Stem Cell Res2016
27848216Questions about NgAgo.Protein Cell2016
27596957Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells.Stem Cell Res2016
27416908A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia.Leukemia2016
27037079Genome Editing in Human Pluripotent Stem Cells.Cold Spring Harb Protoc2016
25418680Efficient and allele-specific genome editing of disease loci in human iPSCs.Mol Ther2015
25713465Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.Stem Cells Transl Med2015
25702619Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.Stem Cells2015
25635918Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors.PLoS One2015
25742692A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.Stem Cells Transl Med2015
23765875Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis.Stem Cells2014
25254336Whole-genome sequencing identifies genetic variances in culture-expanded human mesenchymal stem cells.Stem Cell Reports2014
24996165Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.Cell Stem Cell2014
25114263Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.Blood2014
25132547Synaptic dysregulation in a human iPS cell model of mental disorders.Nature2014
24361925Concise review: stem cell-based approaches to red blood cell production for transfusion.Stem Cells Transl Med2014
24357517Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality.Hum Mutat2014
24132657Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013.Ann Biomed Eng2014
24105986Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.Stem Cells2014
24002691Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.Mol Ther2014
23372166RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.Blood2013
24839581Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements.Bone Res2013
24511466A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells.Stem Cell Reports2013
  • 1 - 50 of 145

Recommended Authors

Massachusetts Institute of Technology
Career Start Year 2008
Number of shared co-authors 7
Medical University of Vienna
Career Start Year 2005
Number of shared co-authors 0
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year 2004
Number of shared co-authors 2
Stanford University
Career Start Year 2004
Number of shared co-authors 3
BioMarin Pharmaceutical Inc.
Career Start Year 2003
Number of shared co-authors 0
University of Macau
Career Start Year 2002
Number of shared co-authors 4
University of Washington
Career Start Year 2002
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 1999
Number of shared co-authors 0
Center for Reproductive Science, University of California los angeles
Career Start Year 1999
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1999
Number of shared co-authors 0
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year 1998
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 3
Joslin Diabetes Center
Career Start Year 1996
Number of shared co-authors 2
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 0
Translational Research Center, Hiroshima University
Career Start Year 1992
Number of shared co-authors 0
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 1
Center for Cancer Innovation, University of Washington
Career Start Year 1991
Number of shared co-authors 1
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year 1990
Number of shared co-authors 3
Inc., Salk Institute for Biological Studies
Career Start Year 1989
Number of shared co-authors 4
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 2
Carpenter Group Consulting Inc., USA NxCell Inc., USA Q Therapeutics Inc.
Career Start Year 1988
Number of shared co-authors 5
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Career Start Year 1987
Number of shared co-authors 1
Albert Einstein College of Medicine
Career Start Year 1987
Number of shared co-authors 0
Center for Molecular Medicine, University of Georgia
Career Start Year 1986
Number of shared co-authors 0
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year 1984
Number of shared co-authors 0
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year 1981
Number of shared co-authors 4
Leiden University Medical Center
Career Start Year 1981
Number of shared co-authors 4
Vita-Salute San Raffaele University
Career Start Year 1980
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 2

Collaborators

Center for Biologics Evaluation and Research
Co-authored papers 51
University of California San Diego
Co-authored papers 16
The Institute for Cell Engineering, Johns Hopkins University
Co-authored papers 16
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 12
Johns Hopkins University School of Medicine, Institute for Cell Engineering
Co-authored papers 12
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers 11
Heidelberg University
Co-authored papers 11
and Blood Institute, National Institutes of Health
Co-authored papers 10
GC Therapeutics Inc.
Co-authored papers 9
and Blood Institute, National Institutes of Health
Co-authored papers 9
Guangzhou University
Co-authored papers 8
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 7
Duke University, Johns Hopkins University
Co-authored papers 5
University of California irvine
Co-authored papers 5
Beijing Institute for Brain Disorders
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Daegu Catholic University Medical Center, Catholic University of Daegu
Co-authored papers 4
The Johns Hopkins University School of Medicine
Co-authored papers 4
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 3
and Blood Institute, National Institutes of Health
Co-authored papers 3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 3
Roswell Park Comprehensive Cancer Center
Co-authored papers 3
The Johns Hopkins University School of Medicine
Co-authored papers 3
Key Laboratory of Longevity and Aging-related Diseases(Guangxi Medical University)
Co-authored papers 3
Johns Hopkins Hospital
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3